SELLAS Offering Friday, November 20, 2026 -0.60 Negative

SELLAS Life Sciences files Underwriting Agreement

SELLAS Life Sciences Group filed a prospectus to initially sell 11.5M shares of common stock, with underwriters J.P. Morgan and TD Securities, while also reserving options to sell up to 1.7M additional shares.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

START FREE — 10,000 calls/day, no key needed